Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Recruiting now · Phase 4
Conditions studied: Sepsis, Infections, Bacteremia
In brief
A challenge to intermittent vancomycin dosing in young infants is the avoidable delay caused by the need to wait until steady state (i.e. when the drug concentrations are in equilibrium) to measure a vancomycin concentration, as this generally occurs 24 to 48 hours after starting treatment. If the target concentration is not achieved, the dose needs to be adjusted, resulting in further delays in an infant achieving the concentration required to treat their infection. The purpose of this study is to assess the use of early therapeutic drug monitoring (first-dose trough) and, if needed, early dose adjustment, in achieving target vancomycin concentrations at steady state. A dose adjustment calculator (available through a web application) will be used to determine the need for dose adjustment (based on predicted steady state concentration) and recommend an adjusted dose if required.
Key facts
- Study ID
- NCT05770622
- Run by
- Murdoch Childrens Research Institute
- People needed
- 40
- Starts
- 2024-11-10
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2026-04-20
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Infants aged 0 - 90 days old
- Suspected infection requiring treatment with vancomycin for 48 hours or more (as determined by the clinical team)
You may not qualify if…
- Infants with a corrected gestational age of less than 25 weeks
- Infants weighing less than 500g.
- Known allergy to any glycopeptide antibiotic
- Vancomycin administered within the previous 72 hours
- Infants receiving any form of extracorporeal life support
- Renal impairment
Where it is running
- Royal Children's Hospital Melbourne — Melbourne, Victoria, Australia (enrolling)
- The Children's Hospital at Westmead — Sydney, Australia (enrolling)
- Monash Newborn — Melbourne, Australia
- Royal Hospital for Women — Sydney, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.